These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33088639)

  • 21. High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome.
    Onuma H; Tohyama M; Imagawa A; Hanafusa T; Kobayashi T; Kano Y; Ohashi J; Hashimoto K; Osawa H; Makino H; ;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2277-81. PubMed ID: 23071161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathy.
    Okahata S; Sakamoto K; Mitsumatsu T; Kondo Y; Noso S; Ikegami H; Shiba T
    Endocr J; 2019 Apr; 66(4):295-300. PubMed ID: 30814440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Case of Fulminant Type 1 Diabetes with Gastric and Urinary Retention.
    Xing C; Zhao W; Wang Y
    Diabetes Ther; 2019 Feb; 10(1):291-298. PubMed ID: 30460498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fulminant type 1 diabetes mellitus].
    Imagawa A; Hanafusa T
    Rinsho Byori; 2010 Mar; 58(3):216-24. PubMed ID: 20408439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes.
    Tanaka S; Aida K; Nishida Y; Kobayashi T
    Endocr J; 2013; 60(7):837-45. PubMed ID: 23774118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes.
    Fujisawa R; Haseda F; Tsutsumi C; Hiromine Y; Noso S; Kawabata Y; Mitsui S; Terasaki J; Ikegami H; Imagawa A; Hanafusa T
    Clin Exp Immunol; 2015 Jun; 180(3):452-7. PubMed ID: 25682896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of abrupt onset autoimmune type 1 diabetes mimicking fulminant type 1 diabetes.
    Makino S; Hamada S; Iwata M; Fujiwara M
    Endocr J; 2009; 56(9):1113-7. PubMed ID: 19680007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.
    Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R
    Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fulminant type 1 diabetes: a nationwide survey in Japan.
    Imagawa A; Hanafusa T; Uchigata Y; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Toyoda T; Maruyama T; Makino H
    Diabetes Care; 2003 Aug; 26(8):2345-52. PubMed ID: 12882860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological aspects of 'fulminant type 1 diabetes'.
    Nagata M; Moriyama H; Kotani R; Yasuda H; Kishi M; Kurohara M; Hara K; Yokono K
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S99-103. PubMed ID: 17478003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two cases of "fulminant" type 1 diabetes suggesting involvement of autoimmunity.
    Nakagawa Y; Shimada A; Oikawa Y; Irie J; Shigihara T; Tsumura K; Narumi S; Saruta T
    Ann N Y Acad Sci; 2003 Nov; 1005():359-61. PubMed ID: 14679092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fulminant type I diabetes: the first case report in Thailand.
    Napartivaumnuay N; Suthornthepvarakul T; Deerochanawong C; Sarinnapakorn V; Niramitmahapanya S
    J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S114-7. PubMed ID: 23682534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snap diagnosis of fulminant type 1 diabetes by the normalized glucose/HbA1c ratio.
    Mori JI; Miyakoshi T; Yuzuriha H; Kondo T; Nishimori E; Naka M; Sato A; Komatsu M; Yamashita K; Aizawa T
    Endocr J; 2024 Aug; ():. PubMed ID: 39135233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes.
    Saito D; Oikawa Y; Mizutani G; Inoue K; Hatano M; Inoue I; Noda M; Shimada A
    Endocr J; 2019 Apr; 66(4):329-336. PubMed ID: 30760658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fulminant type 1 diabetes mellitus and fulminant viral myocarditis. A case report and literature review.
    Ohara N; Kaneko M; Kuwano H; Ebe K; Fujita T; Nagai T; Furukawa T; Aizawa Y; Kamoi K
    Int Heart J; 2015; 56(2):239-44. PubMed ID: 25740579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fulminant type 1 diabetes with robust recovery of insulin secretion: a case report.
    Yamashita K; Sato Y; Seki K; Asano J; Funase Y; Yamauchi K; Aizawa T
    Diabetes Res Clin Pract; 2013 May; 100(2):e34-8. PubMed ID: 23433539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy.
    Baden MY; Imagawa A; Abiru N; Awata T; Ikegami H; Uchigata Y; Oikawa Y; Osawa H; Kajio H; Kawasaki E; Kawabata Y; Kozawa J; Shimada A; Takahashi K; Tanaka S; Chujo D; Fukui T; Miura J; Yasuda K; Yasuda H; Kobayashi T; Hanafusa T;
    Diabetol Int; 2019 Jan; 10(1):58-66. PubMed ID: 30800564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical heterogeneity of type 1 diabetes (T1D) found in Asia.
    Park Y; Wintergerst KA; Zhou Z
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28544229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of new-onset Fulminant type 1 diabetes after secondary SARS-CoV-2 infection.
    Wang J; Huang Y; Tao F
    Heliyon; 2024 May; 10(9):e30750. PubMed ID: 38756607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.